Koyfin Home > Directory > Health Care > Abbvie Inc > Capital Expenditures

Abbvie Inc Capital Expenditures Chart (ABBV)

Abbvie Inc annual/quarterly Capital Expenditures from 2011 to 2020.
  • Abbvie Inc Capital Expenditures for the quarter ending September 09, 2020 was $-217m a 24.88% decrease of -54m year over year
  • Abbvie Inc Capital Expenditures for the last 12 months ending September 09, 2020 was $-682m a 19.06% decrease of -130m year over year
  • Abbvie Inc Annual Capital Expenditures for 2019 was $-552m a -15.58% increase of 86m from 2018
  • Abbvie Inc Annual Capital Expenditures for 2018 was $-638m a 17.08% decrease of -109m from 2017
  • Abbvie Inc Annual Capital Expenditures for 2017 was $-529m a 9.45% decrease of -50m from 2016
Other Cash Flow Metrics:
  • Abbvie Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $4,524m a 42.88% increase of 1,940m year over year
  • Abbvie Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $3,124m a 76.27% increase of 2,383m year over year
  • Abbvie Inc Total Revenue for the quarter ending December 12, 2018 was $8,305m a 4.47% increase of 371m year over year
View Chart On Koyfin

Quarterly ABBV Capital Expenditures Data

09/2020$-217m
06/2020$-177m
03/2020$-125m
12/2019$-163m
09/2019$-154m
06/2019$-128m
03/2019$-107m
12/2018$-123m
09/2018$-282m
06/2018$-114m

Annual ABBV Capital Expenditures Data

2019$-552m
2018$-638m
2017$-529m
2016$-479m
2015$-532m
2014$-612m
2013$-491m
2012$-333m
2011$-356m
2010$-448m